"Early stage funding from the likes of BioAdvance is instrumental in the life of a biotech company. Barbara and her team provide not only money, but also extremely valuable guidance, and also exposure to deeper pockets when the time arises. BioAdvance understands the entrepreneur and thus they are able to help entrepreneurs make the bridge from an early nascent start-up to a well funded , thriving corporation. In my case, this certainly would have been less likely without BioAdvance's help, capital and moral support."

Robert Alonso
Yaupon Therapeutics Inc.

Management

Barbrara S. Schilberg
Managing Director and CEO, BioAdvance

Shahram Hejazi. Ph.D.
Venture Partner, BioAdvance

Marie Lindner, M.D.
Venture Partner, BioAdvance

Board of Directors

Samuel P. Katz (Board Chair)
Partner/CEO, Leverage LLC.

John M. Daly, M.D. (Board Vice Chair)
Dean, Temple University School of Medicine
Harry C. Donahoo Professor of Surgery

Brenda D. Gavin, D.V.M.
Partner, Quaker BioVentures, L.P.

Philip P. Gerbino, PharmD. (Immediate Past Chair)
President, University of the Sciences

John Gill
Founder, President, CEO and Director, TetraLogic Pharmaceuticals

Russel E. Kaufman, M.D.
President & CEO, The Wistar Institute

Lauren Lenfest
Director of Alternative Investments, Pennsylvania State Employees' Retirement System

Steven Nichtberger, M.D.
President and CEO, Tengion

J. Larry Jameson, M.D., Ph.D.
Executive Vice President of the University of Pennsylvania for the Health System, and Dean of the University of Pennsylvania School of Medicine

Manuel Stamatakis
CEO, Capital Management Enterprises

ex officio Members

Barbrara S. Schilberg
Managing Director and CEO, BioAdvance

LOGIN

PASSWORD